Android app Apple app link

Medtronic Says FDA Clears InPen App, Clearing Path for Glucose Monitoring System Launch

By MarketWatch   |   1 year ago
Medtronic Says FDA Clears InPen App, Clearing Path for Glucose Monitoring System Launch

Medtronic's Smart MDI system, including a continuous glucose monitor and InPen app with missed meal dose detection, is closer to launch as FDA cleared the app. The company plans a limited market release followed by a broad commercial launch.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.